Wealth Signal

Evidence that discriminates

1. The free exit existed and was not used. Liberty’s Restated Articles, Art. IV §A.2(b): “Each share of Series B Common Stock will be convertible at any time, at the option of the holder thereof, into one fully paid and non-assessable share of Series A Common Stock.” A governance-motivated relinquishment takes the 1-for-1 route, unilaterally, at zero cost. Only a priced sale needs a special committee, Lazard, Cravath, Paul Weiss and Skadden as tax counsel.
2. The company concedes it paid for the votes. Liberty’s own release states the premium in the exchange ratio equals about 1.5% of Liberty Media’s equity market capitalisation as of 30 October 2026. That is the price of the votes, stated by the buyer.
3. He optimised for economics, not influence. 5,484,077 of 6,098,677 shares received — 89.9% — are Series C, which the Articles give no voting power at all.
4. The protection was restored the same day. The Rights Agreement (Ex. 4.1), adopted 4 Nov 2026, triggers at 10% (15% for passive institutions), carries a 2× flip-in at $426.00 per one ten-thousandth of a preferred share, and expires 3 Nov 2027. The 8-K concedes the effect “may be to render more difficult or discourage a merger, tender or exchange offer.”
5. The tax structure was the point. The release: the transaction “was intended to qualify as a tax-free transaction for U.S. federal income tax purposes.” Liberty disclosed unsolicited third-party offers for the Series B shares — selling the block for cash would have been fully taxable. He took the recapitalisation instead.

Inference, labelled: the sequencing — free conversion right declined, premium accepted, non-voting class elected, pill adopted — is mine. The five facts above are in the filings; the reading of them as a priced sale rather than a surrender is my argument.

Evidence that discriminates

1. The board’s own reference point contradicts the board’s own claim. Final Results, 52 weeks to 26 April 2026: net assets £2,452.7m, revenue £5,325.9m, adjusted PBT £538.0m (−4.0%). The most recent quote I could verify is 845.00p on 430.07m shares → market cap £3.63bn → 1.48× net assets. The conclusion is robust across a wide price range: the shares would have to fall below 570p — beneath the 52-week low of 598p — before market cap even reached the cited NAV.
2. The share cap is not arithmetic from the money cap. £100,000,000 ÷ 26,561,540 = £3.765 per share, less than half the traded price. At ~845p the £100m ceiling binds at roughly 11.8m shares. So 26,561,540 is an independently specified, pre-existing block — not a number computed for this programme.
3. Three to one. The RNS sets the directed-to-on-market ratio at 3:1. Independent shareholders receive a quarter of the programme’s buying pressure; the controlling shareholder receives three quarters.
4. Treasury, not cancellation. Repurchased shares “will be held as treasury shares” — preserving the option to reissue them, which a cancellation would destroy.

Unknowable from the evidence — two live hypotheses

Where does 26,561,540 come from? It matches, to the single share, the block MASH Beta Ltd pledged to HSBC Private Bank as security for a derivatives trading facility, and released on 19 June 2025 (RNS ref. 3189W, 21 Aug 2025) — then 5.90% of issued share capital ex-treasury. Two readings survive:

(a) Financing lineage. The number is a specific block with a credit history, now being monetised to the company. Supporting: the same absolute figure persists across 17 months while its percentage of share capital drifts (5.90% then, ~6.17% of 430.07m now) — a legacy absolute, not a freshly computed percentage.

(b) Coincidence of holding size. 26,561,540 is simply the entire shareholding of one Ashley vehicle, which is why it was both pledgeable in full and cappable in full. Against (a): the pledger was MASH Beta Ltd; the RNS names MASH Holdings as the seller. Different named entities.

What distinguishes them: the AGM Notice’s Directed Buyback Contract and Frasers’ holdings-in-company disclosures showing MASH Beta’s and MASH Holdings’ exact separate shareholdings. I could not reach either. Treat (a) as unproven.

Evidence that discriminates

1. Proportion. 16,000,000 shares moved between Blavatnik entities (≈$1.06bn at the ~$66.10 implied by the gift’s reported value). 1,000,000 left the family. The gift is 5.9% of the shares that moved that day. A story that reports 5.9% of the transaction has the wrong headline.
2. A partnership was taken to zero. Rows 5–6 of the Form 4: AIEH contributes 12,000,000 shares to LYB Holdco and reports holdings after of 0. Entities are not emptied to zero as housekeeping; they are emptied when the entity itself is being retired.
3. The filing names its own purpose. The 13D/A states the transfers were made “pursuant to an internal reorganization” — and nothing more. Item 4 incorporates Item 5(c) by reference and offers no further rationale. The document declines to explain the thing it calls a reorganisation.
4. The gift came from the only entity touched that day, not the obvious one. AICH held exactly 1,000,000 shares before the reorganisation and gifted exactly 1,000,000. Meanwhile AI Chemical Holdings LLC sat untouched with 5,270,918 shares. Inference, labelled: an exact match between a pre-existing balance and a gift size is consistent with gifting a specific low-basis lot, which maximises the deduction while avoiding the gain. Form 4 does not disclose basis, so this is a reading of the pattern, not a disclosed fact.

Evidence that discriminates

1. The March 2025 lot was contractual. 1,043,406 shares at $23.96 (≈$25.0m) on 21 March 2025, acquired directly from Intel under a 10 March 2025 offer letter, priced at the previous day’s close. A purchase from the issuer at a pre-agreed price under an employment document is not a judgement about value on that date.
2. The August 2026 lot matches an offering price exactly. 105,263 shares at $95.00 on 11 August 2026 — precisely $10,000,000, and precisely the price of Intel’s upsized $20bn stock offering that priced the same day. Round dollar amount, round price, same day.
3. Only the November lot has the markers of a free choice at a market price: code P, 10b5-1 unchecked, an untidy weighted average of $64.7312 across multiple fills.

Inference, labelled and important: the link between the August lot and the offering is drawn from the price coincidence, reported by 24/7 Wall St.; the Form 4 itself does not state the shares came from the offering. This is the weakest leg of the item and I am marking it as such rather than leaning on it.

Evidence that discriminates

1. The denominator. 6 departures against ~214 California billionaires is 2.8%. An “exodus” frame requires a rate the data does not contain. The Legislative Analyst’s Office put the income-tax cost of departures at less than $1bn a year.
2. Revealed preference of the exposed. The 22 named billionaire opponents held combined wealth of $722.1bn as of 1 September 2026 (IPS/TURN), implying roughly $36bn of Prop 40 liability. They gave over $150m — about 0.4% of the liability. Total opposition spending across Props 40, 41 and 42 reached $316.7m; Prop 42 alone drew $159m. Measured as insurance, the premium was cheap and the coverage was better than relocation: moving costs you your life, the campaign cost 0.4%.
3. The residency test date was already in the past. Prop 40 keyed liability to residence on 1 January 2026. By the time the campaign was fought in autumn 2026, leaving California could not avoid the tax — the only people mobility ever helped were those who had already gone. Every “they’ll just leave” argument made during the campaign was, as to this measure, inapplicable on its face.
4. The asymmetric outcome. Prop 40 failing kills one tax. Prop 42 passing bars the category — by statute and constitutional amendment — and adds a ban on retroactive application absent a budget emergency. Lorena Gonzalez is right that voters can undo it, but the default has flipped, and defaults are what compound.